References
- Glenny, A., C. Pope, H. Waddington, and U. Wallace. 1926. The antigenic value of toxoid precipitated by potassium alum. J. Pathol. Bacteriol. 26: 38-39.
- Hutchison, S., R. A. Benson, V. B. Gibson, A. H. Pollock, P. Garside, and J. M. Brewer. 2012. Antigen depot is not required for alum adjuvanticity. FASEB J. 26: 1272-1279. https://doi.org/10.1096/fj.11-184556
- Munks, M. W., A. S. McKee, M. K. Macleod, R. L. Powell, J. L. Degen, N. A. Reisdorph, J. W. Kappler, and P. Marrack. 2010. Aluminum adjuvants elicit fibrin-dependent extracellular traps in vivo. Blood 116: 5191-5199. https://doi.org/10.1182/blood-2010-03-275529
- Kool, M., T. Soullié, M. van Nimwegen, M. A. Willart, F. Muskens, S. Jung, H. C. Hoogsteden, H. Hammad, and B. N. Lambrecht. 2008. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J. Exp. Med. 205: 869-882. https://doi.org/10.1084/jem.20071087
- Kool, M., V. Pétrilli, T. De Smedt, A. Rolaz, H. Hammad, M. van Nimwegen, I. M. Bergen, R. Castillo, B. N. Lambrecht, and J. Tschopp. 2008. Cutting edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome. J. Immunol. 181: 3755-3759. https://doi.org/10.4049/jimmunol.181.6.3755
- Li, H., S. B. Willingham, J. P. Ting, and F. Re. 2008. Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3. J. Immunol. 181: 17-21. https://doi.org/10.4049/jimmunol.181.1.17
- Eisenbarth, S. C., O. R. Colegio, W. O'Connor, F. S. Sutterwala, and R. A. Flavell. 2008. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 453: 1122-1126. https://doi.org/10.1038/nature06939
- Franchi, L. and G. Núñez. 2008. The Nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1beta secretion but dispensable for adjuvant activity. Eur. J. Immunol. 38: 2085-2089. https://doi.org/10.1002/eji.200838549
- McKee, A. S., M. W. Munks, M. K. MacLeod, C. J. Fleenor, N. Van Rooijen, J. W. Kappler, and P. Marrack. 2009. Alum induces innate immune responses through macrophage and mast cell sensors, but these sensors are not required for alum to act as an adjuvant for specific immunity. J. Immunol. 183: 4403-4414. https://doi.org/10.4049/jimmunol.0900164
- Allen, A. C., L. Layward, S. J. Harper, and J. Feehally. 1994. In vitro immunoglobulin isotype suppression in immunoglobulin A nephropathy. Exp. Nephrol. 2: 166-170.
- Wang, H. B. and P. F. Weller. 2008. Pivotal advance: eosinophils mediate early alum adjuvant-elicited B cell priming and IgM production. J. Leukoc. Biol. 83: 817-821. https://doi.org/10.1189/jlb.0607392
- Shah, H. B., T. S. Devera, P. Rampuria, G. A. Lang, and M. L Lang. 2012. Type II NKT cells facilitate Alum-sensing and humoral immunity. J. Leukoc. Biol. 92: 883-893. https://doi.org/10.1189/jlb.0412177
- Peng, S. L. 2005. Signaling in B cells via Toll-like receptors. Curr. Opin. Immunol. 17: 230-236. https://doi.org/10.1016/j.coi.2005.03.003
- Nakamura, M., S. Kondo, M. Sugai, M. Nazarea, S. Imamura, and T. Honjo. 1996. High frequency class switching of an IgM+ B lymphoma clone CH12F3 to IgA+ cells. Int. Immunol. 8: 193-201. https://doi.org/10.1093/intimm/8.2.193
- Park, S. R., J. H. Lee, and P. H. Kim. 2001. Smad3 and Smad4 mediate transforming growth factor-beta1-induced IgA expression in murine B lymphocytes. Eur. J. Immunol. 31: 1706-1715. https://doi.org/10.1002/1521-4141(200106)31:6<1706::AID-IMMU1706>3.0.CO;2-Z
- Gonda, H., M. Sugai, Y. Nambu, T. Katakai, Y. Agata, K. J. Mori, Y. Yokota, and A. Shimizu. 2003. The balance between Pax5 and Id2 activities is the key to AID gene expression. J. Exp. Med. 198: 1427-1437. https://doi.org/10.1084/jem.20030802
- Kim, P. H. and M. F. Kagnoff. 1990. Transforming growth factor beta 1 increases IgA isotype switching at the clonal level. J. Immunol. 145: 3773-3778.
- Bergstedt-Lindqvist, S., H. B. Moon, U. Persson, G. Möller, C. Heusser, and E. Severinson. 1988. Interleukin 4 instructs uncommitted B lymphocytes to switch to IgG1 and IgE. Eur. J. Immunol. 18: 1073-1077. https://doi.org/10.1002/eji.1830180716
- Muramatsu, M., K. Kinoshita, S. Fagarasan, S. Yamada, Y. Shinkai, and T. Honjo. 2000. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102: 553-563. https://doi.org/10.1016/S0092-8674(00)00078-7
- Li, S. C., P. B. Rothman, J. Zhang, C. Chan, D. Hirsh, and F. W. Alt. 1994. Expression of I mu-C gamma hybrid germline transcripts subsequent to immunoglobulin heavy chain class switching. Int. Immunol. 6: 491-497. https://doi.org/10.1093/intimm/6.4.491
- Kinoshita, K., M. Harigai, S. Fagarasan, M. Muramatsu, and T. Honjo. 2001. A hallmark of active class switch recombination: transcripts directed by I promoters on looped-out circular DNAs. Proc. Natl. Acad. Sci. U. S. A. 98: 12620-12623. https://doi.org/10.1073/pnas.221454398
- Revy, P., T. Muto, Y. Levy, F. Geissmann, A. Plebani, O. Sanal, N. Catalan, M. Forveille, R. Dufourcq-Labelouse, A. Gennery, I. Tezcan, F. Ersoy, H. Kayserili, A. G. Ugazio, N. Brousse, M. Muramatsu, L. D. Notarangelo, K. Kinoshita, T. Honjo, A. Fischer, and A. Durandy. 2000. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 102: 565-575. https://doi.org/10.1016/S0092-8674(00)00079-9
- Marichal, T., K. Ohata, D. Bedoret, C. Mesnil, C. Sabatel, K. Kobiyama, P. Lekeux, C. Coban, S. Akira, K. J. Ishii, F. Bureau, and C. J. Desmet. 2011. DNA released from dying host cells mediates aluminum adjuvant activity. Nat. Med. 17: 996-1002. https://doi.org/10.1038/nm.2403
- Flach, T. L., G. Ng, A. Hari, M. D. Desrosiers, P. Zhang, S. M. Ward, M. E. Seamone, A. Vilaysane, A. D. Mucsi, Y. Fong, E. Prenner, C. C. Ling, J. Tschopp, D. A. Muruve, M. W. Amrein, and Y. Shi. 2011. Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity. Nat. Med. 17: 479-487. https://doi.org/10.1038/nm.2306
Cited by
- Evaluating the efficacy of rBmHATαc as a multivalent vaccine against lymphatic filariasis in experimental animals and optimizing the adjuvant formulation vol.32, pp.1, 2013, https://doi.org/10.1016/j.vaccine.2013.10.083
- Influenza Vaccines: A Moving Interdisciplinary Field vol.6, pp.10, 2013, https://doi.org/10.3390/v6103809
- Differential Immune Responses in Mice Immunized with Recombinant Neutralizing Epitope Protein of Hepatitis E Virus Formulated with Liposome and Alum Adjuvants vol.29, pp.6, 2016, https://doi.org/10.1089/vim.2016.0024
- Immunotherapeutic Potential of Mollusk Hemocyanins in Combination with Human Vaccine Adjuvants in Murine Models of Oral Cancer vol.2019, pp.None, 2013, https://doi.org/10.1155/2019/7076942